Advances in long-acting therapeutics meeting Advances in long-acting therapeutics meeting | Conference | CELT- Centre of Excellence for Long-acting Therapeutics

About the event

Taking place Monday 7 - Tuesday 8 October 2024, at the Liverpool Medical Institution and Conference Centre, the free Advances in Long-acting Therapeutics Meeting aims to bring together researchers in the area of long-acting therapies, from multiple disciplines, to discuss the current state-of-the-art and future opportunities. The development of long-acting therapeutics is accelerated with a multi-disciplinary approach, to ensure that the therapies being developed with desirable physical properties as materials are viable therapeutically, as well as feasible for translation into a medicinal product. We welcome input from material scientists, pharmacologists, pharmacists and industrial researchers to share current research strategies as well as help to identify challenges along the development pipeline.

The meeting will cover three main topics of discussion:

Current long-acting therapy technologies
Challenges within long-acting therapeutics to be addressed
Future opportunities for development and collaboration.

Don't miss this opportunity to network with experts in the field and learn about cutting-edge research.

The agenda

We're pleased to announce our Keynote Speakers and their titles:

Professor Ryan Donnelly from the School of Pharmacy at Queen's University Belfast

Microneedle systems for administration of long-acting therapeutics

Professor René Holm from the Department of Physics, Chemistry and Pharmacy at Syddansk Universitet (University of Southern Denmark)

Formulating stable suspensions for long-acting applications

Monday 7 October

10:00	Registration
Session 1		Chair: Professor Steve Rannard
11:00	Welcome
11:15	Professor René Holm University of Southern Denmark	Formulating stable suspensions for long-acting applications
12:00	Kevin Treacher AstraZeneca	Nanomedicines as potential long-acting therapeutics
12.30	Tom Starkey Selleck	Sponsor presentation
12:35	Lunch and poster session (sponsored by Selleck)
Session 2		Chair: Karen Alvey
13:35	Professor Steve Rannard University of Liverpool	Long-acting therapeutics in the UK. Future considerations and opportunities
14:00	Dr Garry Laverty Queens University Belfast	Peptide-like hydrogels as long-acting injectable platforms for combined HIV/AIDS-contraceptive drug delivery
14:30	Dr Tom McDonald University of Manchester	In situ forming implants based on nanogels for long-acting drug delivery
15:00	Refreshment break
Session 3 – Sponsored by Marama Labs		Chair: Laxman Cherkupally
15:30	Catherine Unsworth University of Liverpool	Preclinical development of long-acting injectable formulations of glecaprevir and pibrentasvir for hepatitis C treatment in low- and middle-income countries
15:50	Dr Eduardo Gallardo-Toledo University of Liverpool	Dose linearity studies of a glecaprevir and pibrentasvir long-acting injectable formulation in Sprague Dawley rats
16:10	Dr Christos Tapeinos University of Manchester	Cell membrane-derived nanoparticles as highly selective brain-targeted drug delivery systems
16:30	Luke Wingrave University of Liverpool	Niclosamide exerts its immune modulatory properties primarily through altered glucose homeostasis and subsequent changes in immune cell bioenergetics - towards a rational development for long-acting immunotherapy
17:00	Darren Andrews Marama Labs	Sponsor presentation
17:05	Wine reception and poster session (sponsored by Selleck)
19:00	Close

Tuesday 8 October

08:15	Refreshments
Session 1		Chair: Andrew Owen
09:15	Professor Ryan Donnelly Queens University Belfast	Microneedle systems for administration of long-acting therapeutics
10:00	Dr Maria Marlow University of Nottingham	Addressing unresolved challenges in cancer therapy using localised drug delivery
10:30	Refreshment break
Session 2: Sponsored by Marks & Clerk		Chair: Garry Laverty
11:00	Dr James Hobson University of Liverpool	Development of long-acting injectable formulations of next generation diarylquinolines for preventive therapy of tuberculosis infection
11.20	Dr Karen Alvey University of Nottingham	Delivering a step-change in the characterisation of complex medicines
11:40	Ross Kelly AstraZeneca	SubQ-Sim: A Physiologically Based Biopharmaceutics Model (PBBM) for Advancing Subcutaneous Drug Delivery
12:10	Sam Morris University of Liverpool	Dissolving microarray patches for malaria chemoprophylaxis: Mapping solid drug nanoparticle incorporation and long-acting release in vivo
12:30	Representative Marks & Clerk	Sponsor presentation
12:35	Lunch and poster session (sponsored by Selleck)
Session 3		Chair: Christos Tapeinos
13:30	Laxman Cherkupally Medicines for Malaria Venture	Long Acting Injectables - The Future of Affordable Malaria Prevention
14:00	Mark Ryan and Prajith Venkatasubramanian University of Liverpool	LAPaL - An Innovative Tool for Tracking Global Advances in Long-acting Therapeutics Clinical Development and Regulatory Approval
14:30	Poster prize (sponsored by Selleck) and close

You can read all of the abstracts for both the oral and poster presentations here.

How do I register to attend?

To register for attendance, please click here to book a ticket on our Eventbrite page.

How do I submit an abstract for speaker or poster presentation consideration?

Abstract submissions for the 2024 Advances in Long-acting Therapeutics Meeting have now closed.

Additional considerations for presentation applicants

Presenting delegates understand that images and recordings may be taken by the CELT team for social media and advertising purposes of this and future events, please let us know if your submission if you would prefer for you and/or your work not to be included.

In order to make the presentations available to those who cannot attend, all presentations will be recorded and made available via the CELT youtube channel, if you do not wish for your presentation to be made public, please indicate this in your submission.

Please pass conference information on to your interested colleagues

We have several different assets available for you to download and share the event details to people you think will be interested.

Poster

We have a digital poster PDF for the event with incorporated links that is also ready for printing if desired. You are welcome to download the Advances in long-acting therapeutics meeting poster.

Social media assets

The 'book now' and 'submit your abstract now' images are both available as social media assets in a JPG format. Please contact us on askcelt@liverpool.ac.uk to request them.

Can I sponsor this event?

We are currently seeking sponsorship for this event. This conference is an excellent platform for potential partners to showcase their products and services to the researchers at the forefront of this rapid expanded field and facilitate potential collaborations.

Sponsorship opportunities include:

Bronze (£50): Your logo on advertising emails and placeholder slides at the event
Silver (£100): All Bronze benefits plus the opportunity to have a stand at the event and engage with researchers during lunch
Gold (£200): All Silver benefits plus the opportunity to sponsor one of our main sessions (subject to availability), with specific acknowledgment at the beginning of the session and a five-minute talk about your company
Poster prize Sponsor (£250). SOLD OUT.

We currently have one space left for stands.

If you are interested in sponsoring this event, please contact Dr Sam Naghibi by emailing sam22@liverpool.ac.uk.

Thank you for considering this opportunity. We look forward to the possibility of partnering with you.

We gratefully acknowledge financial support from the Royal Society of Chemistry collaborations grant, which has enabled this event to be free from registrations costs for delegates. Thanks also go to Selleck for sponsoring the Poster prizes and Marama Labs for event sponsorship.